Literature DB >> 30761608

Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.

Akihiro Ishii1, Miki Furusho1, Wendy Macklin2, Rashmi Bansal1.   

Abstract

Multiple extracellular and intracellular signals regulate the functions of oligodendrocytes as they progress through the complex process of developmental myelination and then maintain a functionally intact myelin sheath throughout adult life, preserving the integrity of the axons. Recent studies suggest that Mek/ERK1/2-MAPK and PI3K/Akt/mTOR intracellular signaling pathways play important, often overlapping roles in the regulation of myelination. However, it remains poorly understood whether they function independently, sequentially, or converge using a common mechanism to facilitate oligodendrocyte differentiation, myelin growth, and maintenance. To address these questions, we analyzed multiple genetically modified mice and asked whether the deficits due to the conditional loss-of-function of ERK1/2 or mTOR could be abrogated by simultaneous constitutive activation of PI3K/Akt or Mek, respectively. From these studies, we concluded that while PI3K/Akt, not Mek/ERK1/2, plays a key role in promoting oligodendrocyte differentiation and timely initiation of myelination through mTORC1 signaling, Mek/ERK1/2-MAPK functions largely independently of mTORC1 to preserve the integrity of the myelinated axons during adulthood. However, to promote the efficient growth of the myelin sheath, these two pathways cooperate with each other converging at the level of mTORC1, both in the context of normal developmental myelination or following forced reactivation of the myelination program during adulthood. Thus, Mek/ERK1/2-MAPK and the PI3K/Akt/mTOR signaling pathways work both independently and cooperatively to maintain a finely tuned, temporally regulated balance as oligodendrocytes progress through different phases of developmental myelination into adulthood. Therapeutic strategies aimed at targeting remyelination in demyelinating diseases are expected to benefit from these findings.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  differentiation; myelin; myelination; myelinogenesis; oligodendrocyte

Mesh:

Substances:

Year:  2019        PMID: 30761608      PMCID: PMC6571146          DOI: 10.1002/glia.23602

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  66 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

2.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

3.  Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

Authors:  JinXiang Dai; Kathryn K Bercury; Wendy B Macklin
Journal:  Glia       Date:  2014-07-25       Impact factor: 7.452

4.  The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.

Authors:  M M Chou; J Blenis
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

5.  Role of ERK1/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS.

Authors:  Akihiro Ishii; Miki Furusho; Jeffrey L Dupree; Rashmi Bansal
Journal:  J Neurosci       Date:  2014-11-26       Impact factor: 6.167

6.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

7.  Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.

Authors:  Emily P Harrington; Chao Zhao; Stephen P J Fancy; Sovann Kaing; Robin J M Franklin; David H Rowitch
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

8.  The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation.

Authors:  Sharyl L Fyffe-Maricich; J Colleen Karlo; Gary E Landreth; Robert H Miller
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

9.  Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.

Authors:  Frédéric Lebrun-Julien; Lea Bachmann; Camilla Norrmén; Martin Trötzmüller; Harald Köfeler; Markus A Rüegg; Michael N Hall; Ueli Suter
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

10.  A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching.

Authors:  V Younes-Rapozo; L O R Felgueiras; N L Viana; I M Fierro; C Barja-Fidalgo; A C Manhães; P C Barradas
Journal:  Int J Dev Neurosci       Date:  2009-09-01       Impact factor: 2.457

View more
  25 in total

Review 1.  Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination.

Authors:  Fabien Binamé; Lucas D Pham-Van; Dominique Bagnard
Journal:  Cell Mol Life Sci       Date:  2021-05-21       Impact factor: 9.261

Review 2.  Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.

Authors:  Yan Wang; Fuzheng Guo
Journal:  Biol Rev Camb Philos Soc       Date:  2021-11-22

3.  Characterization of EGR-1 Expression in the Auditory Cortex Following Kanamycin-Induced Hearing Loss in Mice.

Authors:  Man Wang; Yuechen Han; Xue Wang; Shuo Liang; Chuan Bo; Zhenbiao Zhang; Mingming Wang; Lei Xu; Daogong Zhang; Wenwen Liu; Haibo Wang
Journal:  J Mol Neurosci       Date:  2021-01-09       Impact factor: 3.444

Review 4.  Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders.

Authors:  Jan Spaas; Lieve van Veggel; Melissa Schepers; Assia Tiane; Jack van Horssen; David M Wilson; Pablo R Moya; Elisabeth Piccart; Niels Hellings; Bert O Eijnde; Wim Derave; Rudy Schreiber; Tim Vanmierlo
Journal:  Cell Mol Life Sci       Date:  2021-03-10       Impact factor: 9.261

5.  Life-long oligodendrocyte development and plasticity.

Authors:  Akiko Nishiyama; Takahiro Shimizu; Amin Sherafat; William D Richardson
Journal:  Semin Cell Dev Biol       Date:  2021-03-16       Impact factor: 7.727

Review 6.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

7.  Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation.

Authors:  Katrina L Adams; Kristin D Dahl; Vittorio Gallo; Wendy B Macklin
Journal:  Semin Cell Dev Biol       Date:  2020-10-22       Impact factor: 7.499

8.  PAK1 Positively Regulates Oligodendrocyte Morphology and Myelination.

Authors:  Tanya L Brown; Hirokazu Hashimoto; Lisbet T Finseth; Teresa L Wood; Wendy B Macklin
Journal:  J Neurosci       Date:  2021-01-21       Impact factor: 6.709

9.  Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.

Authors:  Akihiro Ishii; Miki Furusho; Rashmi Bansal
Journal:  Glia       Date:  2021-06-22       Impact factor: 7.452

10.  Intrauterine growth restriction followed by oxygen support uniquely interferes with genetic regulators of myelination.

Authors:  Jill Chang; Robert H Lurie; Abhineet Sharma; Mirrah Bashir; Camille M Fung; Robert W Dettman; Maria L V Dizon
Journal:  eNeuro       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.